References
- Tu X-P, Qiu Q-H, Chen L-S, Luo X-N, Lu Z-M, Zhang S-Y, Chen S-H. Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma. BMC Cancer. 2015;15(743):743–747. doi:https://doi.org/10.1186/s12885-015-1727-6
- Steuer CE, El-Deiry M, Parks JR, Higgins KA, Saba NF. An update on larynx cancer. CA Cancer J Clin. 2017;67(1):31–50. doi:https://doi.org/10.3322/caac.21386
- Fong PY, Tan SH, Lim DWT, Tan EH, Ng QS, Sommat K, Tan DSW, Ang MK. Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC). PLoS One. 2019;14(11):e0224665. doi:https://doi.org/10.1371/journal.pone.0224665
- Wang Y, Zhang D, Yu1 CH, Dong L, Zhang J, et al. MicroRNA-708-5p contributes to the malignant behavior of laryngeal squamous cell carcinoma by directly targeting metastasis suppressor-1. Int J Clin Exp Med. 2019;12(1):597–603.
- Li Z, Zou L, Liu T, Yang A. Prognostic value of BMI for laryngeal squamous cell carcinoma. Cancer Biol Med. 2015;12:394–400. doi:https://doi.org/10.7497/j.issn.2095-3941.2015.0043
- Te Riele RJLM, Dronkers EAC, Wieringa MH, De Herdt MJ, Sewnaik A, Hardillo JA, Baatenburg de Jong RJ. Influence of anemia and BMI on prognosis of laryngeal squamous cell carcinoma: Development of an updated prognostic model. Oral Oncol. 2018;78:25–30. doi:https://doi.org/10.1016/j.oraloncology.2018.01.001
- Gama RR, Song Y, Zhang Q, Brown MC, Wang J, Habbous S, Tong L, Huang SH, O’Sullivan B, Waldron J, et al. Body mass index and prognosis in patients with head and neck cancer. Head Neck. 2017;39(6):1226–1233. doi:https://doi.org/10.1002/hed.24760
- Tan CSY, Read JA, Phan VH, Beale PJ, Peat JK, Clarke SJ. The relationship between nutritional status, inflammatory markers and survival in patients with advanced cancer: a prospective cohort study. Support Care Cancer. 2015;23(2):385–391. doi:https://doi.org/10.1007/s00520-014-2385-y
- Chen Q, Dai Z, Yin D, Yang L-X, Wang Z, Xiao Y-S, Fan J, Zhou J. Negative impact of preoperative platelet-lymphocyte ratio on outcome after hepatic resection for intrahepatic cholangiocarcinoma. Medicine. 2015;94(13):e574–e577. doi:https://doi.org/10.1097/MD.0000000000000574
- Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K. The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer. World J Surg Oncol. 2015;13:194–198. doi:https://doi.org/10.1186/s12957-015-0609-3
- Fu Y, Liu W, Ouyang D, Yang A, Zhang Q. Preoperative neutrophil-to-lymphocyte ratio predicts long-term survival in patients undergoing total laryngectomy with advanced laryngeal squamous cell carcinoma: a single-center retrospective study. Medicine. 2016;95(6):e2689–6. doi:https://doi.org/10.1097/MD.0000000000002689
- Bruixola G, Caballero J, Papaccio F, Petrillo A, Iranzo A, Civera M, Moriana M, Bosch N, Maroñas M, González I, et al. Prognostic Nutritional Index as an independent prognostic factor in locoregionally advanced squamous cell head and neck cancer. ESMO Open. 2018;3(6):e000425. doi:https://doi.org/10.1136/esmoopen-2018-000425
- Wang J, Wang S, Song X, Zeng W, Wang S, Chen F, Ding H. The prognostic value of systemic and local inflammation in patients with laryngeal squamous cell carcinoma. OTT. 2016;9:7177–7185. doi:https://doi.org/10.2147/OTT.S113307
- Hsueh C, Tao L, Zhang M, Cao W, Gong H, Zhou J, Zhou L. The prognostic value of preoperative neutrophils, platelets, lymphocytes, monocytes and calculated ratios in patients with laryngeal squamous cell cancer. Oncotarget. 2017;8(36):60514–60527. doi:https://doi.org/10.18632/oncotarget.16234
- Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. 2015;37(1):103–110. doi:https://doi.org/10.1002/hed.23567
- Valero C, Pardo L, Sansa A, Garcia Lorenzo J, López M, Quer M, León X. Prognostic capacity of Systemic Inflammation Response Index (SIRI) in patients with head and neck squamous cell carcinoma. Head Neck. 2020;42(2):336–343. doi:https://doi.org/10.1002/hed.26010
- Fondevila C, Metges JP, Fuster J, Grau JJ, Palacín A, Castells A, Volant A, Pera M. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer. 2004;90(1):206–215. doi:https://doi.org/10.1038/sj.bjc.6601455
- Schaider H, Oka M, Bogenrieder T, Nesbit M, Satyamoorthy K, Berking C, Matsushima K, Herlyn M. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer. 2003;103(3):335–343. doi:https://doi.org/10.1002/ijc.10775
- Hu P, Shen H, Wang G, Zhang P, Liu Q, Du J. Prognostic significance of systemic inflammation-based lymphocyte- monocyte ratio in patients with lung cancer: Based on a large cohort study. PLoS One. 2014;9(9):e108062 doi:https://doi.org/10.1371/journal.pone.0108062
- Torisu-Itakura H, Lee JH, Huynh Y, Ye X, Essner R, Morton DL. Monocyte derived IL-10 expression predicts prognosis of stage IV melanoma patients. J Immunother. 2007;30(8):831–838. doi:https://doi.org/10.1097/CJI.0b013e318158795b
- Huang CD. Econometric models of alcohol demand in the United Kingdom. Govern Econ Serv Working Paper. 2003;140:1–52.
- Freedman DS, Flanders WD, Barboriak JJ, Malarcher AM, Gates L. Cigarette smoking and leukocyte subpopulations in men. Ann Epidemiol. 1996;6(4):299–306. doi:https://doi.org/10.1016/S1047-2797(96)00024-5
- World Health Organization. Obesity – Presenting and managing the global epidemic. Report of a WHO consultation. Geneva, Switzerland: World Health Organization, 1998.
- OPAS. Organización Panamericana de la Salud. División de Promoción y Protección de la Salud (HPP). Encuesta Multicentrica salud beinestar y envejecimiento (SABE) em América Latina el Caribe: Informe Preliminar [Internet]. In: XXXVI Reunión del Comité asesor de investigaciones em Salud. Kingston, Jamaica: OPAS, 2002.
- Li S, Lan X, Gao H, Li Z, Chen L, Wang W, Song S, Wang Y, Li C, Zhang H, et al. Systemic Inflammation Response Index (SIRI), cancer stem cells and survival of localised gastric adenocarcinoma after curative resection. J Cancer Res Clin Oncol. 2017;143(12):2455–2468. doi:https://doi.org/10.1007/s00432-017-2506-3
- Kumarasamy C, Sabarimurugan S, Madurantakam RM, Lakhotiya K, Samiappan S, Baxi S, Nachimuthu R, Gothandam KM, Jayaraj R. Prognostic significance of blood inflammatory biomarkers NLR, PLR, and LMR in cancer-A protocol for systematic review and meta-analysis. Medicine. 2019;98(24):e14834 doi:https://doi.org/10.1097/MD.0000000000014834
- Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32–35. doi:https://doi.org/10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3
- Hosmer DWJr, Lemeshow S, May S. Applied survival analysis: regression modeling of time-to-event dat. 2nd ed., New Jersey: Wiley Interscience; 2011. ISBN 978-0-471-75499-2.
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (strobe) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:https://doi.org/10.7326/0003-4819-147-8-200710160-00010
- Chandrasekara S, Davis S, Thomson P, Haydon A. High neutrophil‐to‐lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy. Asia-Pac J Clin Oncol. 2018;14(5):e442–e447. doi:https://doi.org/10.1111/ajco.12846
- Yılmaz B, Şengül E, Gül A, Alabalık U, Özkurt FE, Akdağ M, Topçu İ. Neutrophil-lymphocyte ratio as a prognostic factor in laryngeal carcinoma. Indian J Otolaryngol Head Neck Surg. 2018;70(2):175–179. doi:https://doi.org/10.1007/s12070-014-0769-4
- Marchi F, Missale F, Incandela F, Filauro M, Mazzola F, Mora F, Paderno A, Parrinello G, Piazza C, Peretti G, et al. Prognostic significance of peripheral T‐cell subsets in laryngeal squamous cell carcinoma. Head Neck Tumor Biol. 2019;4(5):513–519. doi:https://doi.org/10.1002/lio2.304
- Abelardo E, Davies G, Kamhieh Y, Prabhu V. Are inflammatory markers significant prognostic factors for head and neck cancer patients?ORL. 2020;82(5):1–20. doi:https://doi.org/10.1159/000507027
- Valero C, Zanoni DK, McGill MR, Ganly I, Morris LGT, Quer M, Shah JP, Wong RJ, León X, Patel SG, et al. Pretreatment peripheral blood leukocytes are independent predictors of survival in oral cavity cancer. Cancer. 2020;126(5):994–1003. doi:https://doi.org/10.1002/cncr.32591
- Zhang Y, Liu F, Wang Y. Evidence of the prognostic value of pretreatment systemic inflammation response index in cancer patients: A pooled analysis of 19 cohort studies. Dis Markers. 2020; 2020:1–10. doi:https://doi.org/10.1155/2020/8854267
- Chen Y, Lee Y-CA, Li S, Li Q, Chen C-J, Hsu W-L, Lou P-J, Zhu C, Pan J, Shen H, et al. Body mass index and the risk of head and neck cancer in the Chinese population. Cancer Epidemiol. 2019;60:208–215. doi:https://doi.org/10.1016/j.canep.2019.04.008
- Shaukat A, Dostal A, Menk J, Church TR. BMI is a risk factor for colorectal cancer mortality. Dig Dis Sci. 2017;62(9):2511–2517. doi:https://doi.org/10.1007/s10620-017-4682-z
- Jalal P, Ensiyeh J. The association between BMI and cervical cancer risk: a meta-analysis. Eur J Cancer Prev. 2016;25(3):232–238. doi:https://doi.org/10.1097/CEJ.0000000000000164
- Takenaka Y, Takemoto N, Nakahara S, Yamamoto Y, Yasui T, Hanamoto A, Fukusumi T, Michiba T, Cho H, Yamamoto M, et al. Prognostic significance of body mass index before treatment for head and neck cancer. Head Neck. 2015;37(10):1518–1523. doi:https://doi.org/10.1002/hed.23785
- Nguyen TV, Yueh B. Weight loss predicts mortality after recurrent oral cavity and oropharyngeal carcinomas. Cancer. 2002;95(3):553–562. doi:https://doi.org/10.1002/cncr.10711
- Moon H, Roh J-L, Lee S-w, Kim S-B, Choi S-H, Nam SY, Kim SY. Prognostic value of nutritional and hematologic markers in head and neck squamous cell carcinoma treated by chemoradiotherapy. Radiother Oncol. 2016;118(2):330–334. doi:https://doi.org/10.1016/j.radonc.2015.10.029
- DC. McMillan Cancer and systemic inflammation: stage the tumour and stage the host. Br J Cancer. 2013;109(3):529 doi:https://doi.org/10.1038/bjc.2013.418
- Zhang L, Su Y, Chen Z, Wei Z, Han W, Xu A. The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction. Medicine. 2017;96(30):e7647. doi:https://doi.org/10.1097/MD.0000000000007647
- Cespedes Feliciano EM, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, et al. Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer results from the C SCANS Study. JAMA Oncol. 2017;3(12):e172319. doi:https://doi.org/10.1001/jamaoncol.2017.2319
- Barker T, Fulde G, Moulton B, Nadauld LD, Rhodes T. An elevated neutrophil-to-lymphocyte ratio associates with weight loss and cachexia in cancer. Sci Rep. 2020;10(1):7535. doi:https://doi.org/10.1038/s41598-020-64282-z
- De Giorgi U, Procopio G, Giannarelli D, Sabbatini R, Bearz A, Buti S, Basso U, Mitterer M, Ortega C, Bidoli P, et al. Association of systemic inflammation index and body mass index with survival in patients with renal cell cancer treated with nivolumab. Clin Cancer Res. 2019;25(13):3839–3846. doi:https://doi.org/10.1158/1078-0432.CCR-18-3661
- Fang Q, Tong Y-W, Wang G, Zhang N, Chen W-G, Li Y-F, Shen K-W, Wu B-W, Chen X-S. Neutrophil-to-lymphocyte ratio, obesity, and breast cancer risk in Chinese population. Medicine. 2018;97(30):e11692. doi:https://doi.org/10.1097/MD.0000000000011692
- Liu Z, Wang H, Chen Y, Jin J, Yu W. Obesity: An independent protective factor for localized renal cell carcinoma in a systemic inflammation state. Int Braz J Urol. 2020;46(4):585–598. doi:https://doi.org/10.1590/s1677-5538.ibju.2019.0228